The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A
Open accessAbstract
Many solid cancers display cellular hierarchies with self-renewing, tumorigenic stemlike cells, or cancer-initiating cells (CICs) at the apex. Whereas CICs often exhibit relative resistance to conventional cancer therapies, they also receive critical maintenance cues from supportive stromal elements that also respond to cytotoxic therapies. To interrogate the interplay between chemotherapy and CICs, we investigated cellular heterogeneity in human colorectal cancers. Colorectal CICs were resistant to conventional chemotherapy in cell-autonomous assays, but CIC chemoresistance was also increased by cancer-associated fibroblasts (CAFs). Comparative analysis of matched colorectal cancer specimens from patients before and after cytotoxic treatment revealed a significant increase in CAFs. Chemotherapy-treated human CAFs promoted CIC self-renewal and in vivo tumor growth associated with increased secretion of specific cytokines and chemokines, including interleukin-17A (IL-17A). Exogenous IL-17A increased CIC self-renewal and invasion, and targeting IL-17A signaling impaired CIC growth. Notably, IL-17A was overexpressed by colorectal CAFs in response to chemotherapy with expression validated directly in patient-derived specimens without culture. These data suggest that chemotherapy induces remodeling of the tumor microenvironment to support the tumor cellular hierarchy through secreted factors. Incorporating simultaneous disruption of CIC mechanisms and interplay with the tumor microenvironment could optimize therapeutic targeting of cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Identification of stem cells in small intestine and colon by marker gene Lgr5
Barker, N., van Es, J. H., Kuipers, J., Kujala, P., van den Born, M., Cozijnsen, M., Haegebarth, A., Korving, J., Begthel, H., Peters, P. J., et al. (2007) · Nature · doi:10.1038/nature06196 · Cited by 5,687
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391 · cited 1×
“As cancers mimic development and wound responses (i.e., “the wound that does not heal”; Dvorak, 1986; Schäfer and Werner, 2008), two scenarios in which stem cells function, it is not surprising that cancers display cellular hierarchies and coopt stem cell regulatory mechanisms.”
BackgroundOrimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts
Sato, T., van Es, J. H., Snippert, H. J., Stange, D. E., Vries, R. G., van den Born, M., Barker, N., Shroyer, N. F., van de Wetering, M., & Clevers, H. (2011) · Nature · doi:10.1038/nature09637 · Cited by 2,510
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
Straussman, R., Morikawa, T., Shee, K., Barzily-Rokni, M., Qian, Z. R., Du, J., Davis, A., Mongare, M. M., Gould, J., Frederick, D. T., et al. (2012) · Nature · doi:10.1038/nature11183 · Cited by 1,771
Erez, N., Truitt, M., Olson, P., & Hanahan, D. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.041 · Cited by 1,515
Carcinoma-associated fibroblasts stimulate tumor progression of initiated human epithelium
Olumi, A., Grossfeld, G., Hayward, S., Carroll, P., Cunha, G., Hein, P., & Tlsty, T. (2000) · Breast Cancer Research · doi:10.1186/bcr138 · Cited by 1,463
Adenoma–linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth
Grivennikov, S. I., Wang, K., Mucida, D., Stewart, C. A., Schnabl, B., Jauch, D., Taniguchi, K., Yu, G.-Y., Österreicher, C. H., Hung, K. E., et al. (2012) · Nature · doi:10.1038/nature11465 · Cited by 1,327
Molecular characterization of the tumor microenvironment in breast cancer
Allinen, M., Beroukhim, R., Cai, L., Brennan, C., Lahti-Domenici, J., Huang, H., Porter, D., Hu, M., Chin, L., Richardson, A., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.010 · Cited by 1,299
Research works printed but not linked: 86
- Arnold, 2010, Targeted treatments in colorectal cancer: state of the art and future perspectives, Gut., 59, 838, 10.1136/gut.2009.196006 · DOI
- Barcellos-Hoff, 2000, Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells, Cancer Res., 60, 1254
- Barker, 2009, Crypt stem cells as the cells-of-origin of intestinal cancer, Nature., 457, 608, 10.1038/nature07602 · DOI · Paper page
- Bissell, 2005, Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment?, Cancer Cell., 7, 17
- Blache, 2004, SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes, J. Cell Biol., 166, 37, 10.1083/jcb.200311021 · DOI · Paper page
- Blanpain, 2013, Tracing the cellular origin of cancer, Nat. Cell Biol., 15, 126, 10.1038/ncb2657 · DOI · Paper page
- Bonnet, 1997, Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell, Nat. Med., 3, 730, 10.1038/nm0797-730 · DOI · Paper page
- Bruchard, 2013, Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth, Nat. Med., 19, 57, 10.1038/nm.2999 · DOI · Paper page
- Calon, 2012, Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation, Cancer Cell., 22, 571, 10.1016/j.ccr.2012.08.013 · DOI · Paper page
- Crawford, 2009, PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment, Cancer Cell., 15, 21, 10.1016/j.ccr.2008.12.004 · DOI · Paper page
- Dalerba, 2007, Phenotypic characterization of human colorectal cancer stem cells, Proc. Natl. Acad. Sci. USA., 104, 10158, 10.1073/pnas.0703478104 · DOI · Paper page
- Dallas, 2009, Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition, Cancer Res., 69, 1951, 10.1158/0008-5472.CAN-08-2023 · DOI · Paper page
- De Wever, 2002, Role of myofibroblasts at the invasion front, Biol. Chem., 383, 55, 10.1515/BC.2002.006 · DOI
- Deng, 2010, Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers, PLoS ONE., 5, e10277, 10.1371/journal.pone.0010277 · DOI · Paper page
- Desmoulière, 2004, The stroma reaction myofibroblast: a key player in the control of tumor cell behavior, Int. J. Dev. Biol., 48, 509, 10.1387/ijdb.041802ad · DOI · Paper page
- Du, 2008, CD44 is of functional importance for colorectal cancer stem cells, Clin. Cancer Res., 14, 6751, 10.1158/1078-0432.CCR-08-1034 · DOI · Paper page
- Dylla, 2008, Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy, PLoS ONE., 3, e2428, 10.1371/journal.pone.0002428 · DOI · Paper page
- Elsaba, 2010, The stem cell marker CD133 associates with enhanced colony formation and cell motility in colorectal cancer, PLoS ONE., 5, e10714, 10.1371/journal.pone.0010714 · DOI
- Fang, 2010, Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery, Br. J. Cancer., 102, 1265, 10.1038/sj.bjc.6605610 · DOI
- Gemei, 2013, CD66c is a novel marker for colorectal cancer stem cell isolation, and its silencing halts tumor growth in vivo, Cancer., 119, 729, 10.1002/cncr.27794 · DOI
- Gilbert, 2011, Chemotherapeutic resistance: surviving stressful situations, Cancer Res., 71, 5062, 10.1158/0008-5472.CAN-11-0277 · DOI
- Gonda, 2010, Molecular biology of cancer-associated fibroblasts: can these cells be targeted in anti-cancer therapy?, Semin. Cell Dev. Biol., 21, 2, 10.1016/j.semcdb.2009.10.001 · DOI
- Grum-Schwensen, 2005, Suppression of tumor development and metastasis formation in mice lacking the S100A4(mts1) gene, Cancer Res., 65, 3772, 10.1158/0008-5472.CAN-04-4510 · DOI · Paper page
- Guo, 2012, Slug and Sox9 cooperatively determine the mammary stem cell state, Cell., 148, 1015, 10.1016/j.cell.2012.02.008 · DOI · Paper page
- Hao, 2011, Bone marrow stromal cells protect myeloma cells from bortezomib induced apoptosis by suppressing microRNA-15a expression, Leuk. Lymphoma., 52, 1787, 10.3109/10428194.2011.576791 · DOI
- Hellevik, 2013, Changes in the Secretory Profile of NSCLC-Associated Fibroblasts after Ablative Radiotherapy: Potential Impact on Angiogenesis and Tumor Growth, Transl Oncol., 6, 66, 10.1593/tlo.12349 · DOI
- Hölzel, 2013, Plasticity of tumour and immune cells: a source of heterogeneity and a cause for therapy resistance?, Nat. Rev. Cancer., 13, 365, 10.1038/nrc3498 · DOI · Paper page
- Horst, 2009, Prognostic significance of the cancer stem cell markers CD133, CD44, and CD166 in colorectal cancer, Cancer Invest., 27, 844, 10.1080/07357900902744502 · DOI · Paper page
- Hu, 2009, ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays, J. Immunol. Methods., 347, 70, 10.1016/j.jim.2009.06.008 · DOI · Paper page
- Huang, 2009, Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis, Cancer Res., 69, 3382, 10.1158/0008-5472.CAN-08-4418 · DOI · Paper page
- Hueber, 2010, Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis, Sci. Transl. Med., 2, 52ra72, 10.1126/scitranslmed.3001107 · DOI · Paper page
- Hyun, 2012, Role of IL-17A in the development of colitis-associated cancer, Carcinogenesis., 33, 931, 10.1093/carcin/bgs106 · DOI · Paper page
- Jay, 2005, Expression of the carcinoembryonic antigen gene is inhibited by SOX9 in human colon carcinoma cells, Cancer Res., 65, 2193, 10.1158/0008-5472.CAN-04-1484 · doi:10.1158/0008-5472.can-04-1484
- Lakshman, 2004, CD44 promotes resistance to apoptosis in human colon cancer cells, Exp. Mol. Pathol., 77, 18, 10.1016/j.yexmp.2004.03.002 · DOI · Paper page
- Lakshman, 2005, CD44 promotes resistance to apoptosis in murine colonic epithelium, J. Cell. Physiol., 203, 583, 10.1002/jcp.20260 · doi:10.1002/jcp.20260
- Leonardi, 2012, Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis, N. Engl. J. Med., 366, 1190, 10.1056/NEJMoa1109997 · DOI · Paper page
- Li, 2012, Cancer-stimulated mesenchymal stem cells create a carcinoma stem cell niche via prostaglandin E2 signaling, Cancer Discov., 2, 840, 10.1158/2159-8290.CD-12-0101 · DOI · Paper page
- Lieubeau, 1994, The role of transforming growth factor beta 1 in the fibroblastic reaction associated with rat colorectal tumor development, Cancer Res., 54, 6526
- Liu, 2011, Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks, Cancer Res., 71, 614, 10.1158/0008-5472.CAN-10-0538 · DOI · Paper page
- Lu, 2013, Endothelial cells promote the colorectal cancer stem cell phenotype through a soluble form of Jagged-1, Cancer Cell., 23, 171, 10.1016/j.ccr.2012.12.021 · DOI · Paper page
- Magee, 2012, Cancer stem cells: impact, heterogeneity, and uncertainty, Cancer Cell., 21, 283, 10.1016/j.ccr.2012.03.003 · DOI · Paper page
- Markowitz, 2009, Molecular origins of cancer: Molecular basis of colorectal cancer, N. Engl. J. Med., 361, 2449, 10.1056/NEJMra0804588 · DOI · Paper page
- Markowitz, 1995, Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability, Science., 268, 1336, 10.1126/science.7761852 · DOI · Paper page
- Matsunaga, 2003, Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia, Nat. Med., 9, 1158, 10.1038/nm909 · DOI · Paper page
- Medema, 2011, Microenvironmental regulation of stem cells in intestinal homeostasis and cancer, Nature., 474, 318, 10.1038/nature10212 · DOI · Paper page
- Medzhitov, 2009, Transcriptional control of the inflammatory response, Nat. Rev. Immunol., 9, 692, 10.1038/nri2634 · DOI · Paper page
- Micke, 2004, Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy?, Lung Cancer., 45, S163, 10.1016/j.lungcan.2004.07.977 · DOI · Paper page
- Nakasone, 2012, Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance, Cancer Cell., 21, 488, 10.1016/j.ccr.2012.02.017 · DOI · Paper page
- Nakayama, 2002, Alpha smooth muscle actin positive stromal cells in gastric carcinoma, J. Clin. Pathol., 55, 741, 10.1136/jcp.55.10.741 · DOI
- O’Brien, 2007, A human colon cancer cell capable of initiating tumour growth in immunodeficient mice, Nature., 445, 106, 10.1038/nature05372 · DOI · Paper page
- Ogino, 2012, How many molecular subtypes? Implications of the unique tumor principle in personalized medicine, Expert Rev. Mol. Diagn., 12, 621, 10.1586/erm.12.46 · DOI · Paper page
- Ohata, 2012, Induction of the stem-like cell regulator CD44 by Rho kinase inhibition contributes to the maintenance of colon cancer-initiating cells, Cancer Res., 72, 5101, 10.1158/0008-5472.CAN-11-3812 · DOI
- Orimo, 2007, Heterogeneity of stromal fibroblasts in tumors, Cancer Biol. Ther., 6, 618, 10.4161/cbt.6.4.4255 · DOI
- Papp, 2012, Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis, N. Engl. J. Med., 366, 1181, 10.1056/NEJMoa1109017 · DOI · Paper page
- Park, 1999, Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts, J. Biol. Chem., 274, 36505, 10.1074/jbc.274.51.36505 · DOI · Paper page
- Park, 2012, Differential expression of CD133 based on microsatellite instability status in human colorectal cancer, Mol. Carcinog.
- Peñuelas, 2009, TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma, Cancer Cell., 15, 315, 10.1016/j.ccr.2009.02.011 · DOI · Paper page
- Porter, 2012, Cyclin-dependent kinase 8 mediates chemotherapy-induced tumor-promoting paracrine activities, Proc. Natl. Acad. Sci. USA., 109, 13799, 10.1073/pnas.1206906109 · DOI · Paper page
- Ricci-Vitiani, 2007, Identification and expansion of human colon-cancer-initiating cells, Nature., 445, 111, 10.1038/nature05384 · DOI · Paper page
- Ricci-Vitiani, 2009, Colon cancer stem cells, J. Mol. Med., 87, 1097, 10.1007/s00109-009-0518-4 · DOI · Paper page
- Rønnov-Jessen, 1996, Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction, Physiol. Rev., 76, 69, 10.1152/physrev.1996.76.1.69 · DOI · Paper page
- Sadanandam, 2013, A colorectal cancer classification system that associates cellular phenotype and responses to therapy, Nat. Med., 19, 619, 10.1038/nm.3175 · DOI · Paper page
- Sanchez, 2009, Genetic and epigenetic classifications define clinical phenotypes and determine patient outcomes in colorectal cancer, Br. J. Surg., 96, 1196, 10.1002/bjs.6683 · DOI
- Sappino, 1988, Smooth-muscle differentiation in stromal cells of malignant and non-malignant breast tissues, Int. J. Cancer., 41, 707, 10.1002/ijc.2910410512 · DOI · Paper page
- Schäfer, 2008, Cancer as an overhealing wound: an old hypothesis revisited, Nat. Rev. Mol. Cell Biol., 9, 628, 10.1038/nrm2455 · DOI · Paper page
- Schuijers, 2012, Adult mammalian stem cells: the role of Wnt, Lgr5 and R-spondins, EMBO J., 31, 2685, 10.1038/emboj.2012.149 · DOI · Paper page
- Schwitalla, 2013, Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties, Cell., 152, 25, 10.1016/j.cell.2012.12.012 · DOI · Paper page
- Serini, 1999, Mechanisms of myofibroblast activity and phenotypic modulation, Exp. Cell Res., 250, 273, 10.1006/excr.1999.4543 · DOI · Paper page
- Shaked, 2006, Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors, Science., 313, 1785, 10.1126/science.1127592 · DOI · Paper page
- Shaked, 2008, Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents, Cancer Cell., 14, 263, 10.1016/j.ccr.2008.08.001 · DOI · Paper page
- Shmelkov, 2008, CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors, J. Clin. Invest., 118, 2111
- Sugimoto, 2006, Identification of fibroblast heterogeneity in the tumor microenvironment, Cancer Biol. Ther., 5, 1640, 10.4161/cbt.5.12.3354 · DOI · Paper page
- Takahashi, 2011, Significance of Lgr5(+ve) cancer stem cells in the colon and rectum, Ann. Surg. Oncol., 18, 1166, 10.1245/s10434-010-1373-9 · DOI
- Todaro, 2007, Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4, Cell Stem Cell., 1, 389, 10.1016/j.stem.2007.08.001 · DOI · Paper page
- Tuxhorn, 2002, Inhibition of transforming growth factor-beta activity decreases angiogenesis in a human prostate cancer-reactive stroma xenograft model, Cancer Res., 62, 6021
- Vermeulen, 2008, Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity, Proc. Natl. Acad. Sci. USA., 105, 13427, 10.1073/pnas.0805706105 · DOI · Paper page
- Vermeulen, 2010, Wnt activity defines colon cancer stem cells and is regulated by the microenvironment, Nat. Cell Biol., 12, 468, 10.1038/ncb2048 · DOI · Paper page
- Wang, 2009, Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth, Stem Cells., 27, 2393, 10.1002/stem.188 · DOI · Paper page
- Washington, 2009, Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum, Arch. Pathol. Lab. Med., 133, 1539, 10.5858/133.10.1539 · DOI · Paper page
- Weaver, 2002, beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium, Cancer Cell., 2, 205, 10.1016/S1535-6108(02)00125-3 · DOI · Paper page
- Winder, 2010, Vascular endothelial growth factor and epidermal growth factor signaling pathways as therapeutic targets for colorectal cancer, Gastroenterology., 138, 2163, 10.1053/j.gastro.2010.02.005 · DOI
- Worthley, 2010, Stromal fibroblasts in digestive cancer, Cancer Microenviron., 3, 117, 10.1007/s12307-009-0033-8 · DOI
- Wu, 2009, A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses, Nat. Med., 15, 1016, 10.1038/nm.2015 · DOI · Paper page
- Xing, 2010, Cancer associated fibroblasts (CAFs) in tumor microenvironment, Front Biosci (Landmark Ed)., 15, 166, 10.2741/3613 · DOI · Paper page
- Yamauchi, 2008, Induction of cancer metastasis by cyclophosphamide pretreatment of host mice: an opposite effect of chemotherapy, Cancer Res., 68, 516, 10.1158/0008-5472.CAN-07-3063 · DOI
- Yeung, 2010, Cancer stem cells from colorectal cancer-derived cell lines, Proc. Natl. Acad. Sci. USA., 107, 3722, 10.1073/pnas.0915135107 · DOI · Paper page
Cited by
The biology and function of fibroblasts in cancer
Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366
Understanding and targeting resistance mechanisms in NSCLC
Rotow, J., & Bivona, T. G. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.84 · Cited by 972
Fibroblast heterogeneity in the cancer wound
Öhlund, D., Elyada, E., & Tuveson, D. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20140692 · Cited by 926
Cancer Stem Cells: Basic Concepts and Therapeutic Implications
Nassar, D., & Blanpain, C. (2016) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044438 · Cited by 869
Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer
Wu, F., Yang, J., Liu, J., Wang, Y., Mu, J., Zeng, Q., Deng, S., & Zhou, H. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00641-0 · Cited by 773
Metadata
- Authors
- Lotti, F., Jarrar, A. M., Pai, R. K., Hitomi, M., Lathia, J., Mace, A., Gantt, G. A., Sukhdeo, K., DeVecchio, J., Vasanji, A., Leahy, P., Hjelmeland, A. B., Kalady, M. F., & Rich, J. N.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2013-12-09
- Volume
- 210
- Issue
- 13
- Pages
- 2851-2872
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2102944868
- Cited by
- 359
- References
- 14
- FWCI
- 9.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A. https://app.cochat.ai/papers/10.1084/jem.20131195
- The paper
- Lotti, F., Jarrar, A. M., Pai, R. K., Hitomi, M., Lathia, J., Mace, A., Gantt, G. A., Sukhdeo, K., DeVecchio, J., Vasanji, A., Leahy, P., Hjelmeland, A. B., Kalady, M. F., & Rich, J. N. (2013). Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20131195
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.